Immunogenic Nanovesicle‐Tandem‐Augmented Chemoimmunotherapy via Efficient Cancer‐Homing Delivery and Optimized Ordinal‐Interval Regime

The strategy of combining immune checkpoint inhibitors (ICIs) with anthracycline is recommended by clinical guidelines for the standard‐of‐care treatment of triple‐negative breast cancer (TNBC). Nevertheless, several fundamental clinical principles are yet to be elucidated to achieve a great therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Mengchi, Shi, Wen, Wu, Yuxia, He, Zhonggui, Sun, Jin, Cai, Shuang, Luo, Qiuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811449/
https://www.ncbi.nlm.nih.gov/pubmed/36453573
http://dx.doi.org/10.1002/advs.202205247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811449/
https://www.ncbi.nlm.nih.gov/pubmed/36453573
http://dx.doi.org/10.1002/advs.202205247

Ejemplares similares